NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its fourth quarter and full year 2025 financial results before the market open on Wednesday, February 25, 2026, to be followed by a conference call at 8:30 a.m. Eastern Time. Conference Call Details: To participate in the conference call, please dial 1-877-407-9208 (US) or 1-201-493-6784 (international). To access the call, please reference the company name and call title: ODDITY Fourt ...

FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Cytek management is scheduled to participate in a hybrid presentation and fireside chat on Wednesday, March 4th at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “In ...

Reinforcing Leadership Alignment with Strategic Growth Plans and Long-Term Shareholder InterestsNEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DTST” or the “Company”), today announced that on February 12, 2026, its Board of Directors approved the 2025 annual bonus award for Chairman and Chief Executive Officer Chuck Piluso for the fiscal year ended December 31, 2025. The approved bonus consists of a cash payment within the limits set forth in Mr. Piluso’s current emplo ...

Co-Founder Matt Oppenheimer to Continue as Chairman of the BoardSEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly” or the “Company”) today announced the appointment of Sebastian J. Gunningham as Chief Executive Officer (“CEO”) and member of the Board of Directors (the “Board”), effective February 19, 2026. Mr. Gunningham succeeds Co-Founder Matt Oppenheimer, who decided to transition the role of CEO to a new leader after nearly 15 years of driving transformative growth ...

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolioCARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personalized cervical plating procedure using the corra™ Cervical Plating System, the latest addition to its portfolio of personalized spine surgery solutions. The procedure, which was performed by Dr. Aaron Clark at the University of California San Francisco (UCSF), repre ...

Company Participation - Seer, Inc. will participate in the TD Cowen 46 Annual Health Care Conference in Boston, MA [1] - Management is scheduled for a fireside chat on March 4 at 11:10 a.m. Eastern Time [2] Company Overview - Seer, Inc. is a pioneer in deep, unbiased proteomics, providing insights with unprecedented scale, speed, precision, and reproducibility [3] - The Proteograph Product Suite integrates proprietary engineered nanoparticles, streamlined automation, optimized consumables, and advanced analytical software [3] - Seer's technology addresses challenges faced by traditional proteomic methods, which often struggle with inconsistent data and limited throughput [3] - The products are intended for research use only and are not designed for diagnostic procedures [3]

Core Insights - Heartflow, Inc. is participating in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026, showcasing its leadership in AI technology for coronary artery disease [1] Company Overview - Heartflow is transforming coronary artery disease management, which is the leading cause of death globally, into a condition that can be detected early and managed effectively [4] - The Heartflow One platform utilizes AI to convert coronary CTA images into personalized 3D heart models, providing actionable insights into plaque characteristics and blood flow without invasive procedures [4] Technology and Research - Heartflow's technology is supported by the world's largest coronary imaging dataset, with over 160 million annotated CTA images, enabling advanced AI models that deliver accurate insights across diverse patient populations [5] - The company's AI-driven solutions have been validated through over 200 studies involving more than 365,000 patients, achieving coronary CTA image acceptance rates exceeding 97% [5] - Heartflow's solutions are backed by ACC/AHA guidelines and over 600 peer-reviewed publications, having redefined care management for over 500,000 patients worldwide [3][5] Commercial Presence - Heartflow has been adopted by more than 1,400 institutions globally, indicating a strong commercial presence and commitment to making its technology widely available [3] - The company ensures seamless clinical integration with upgraded workflows, providing quality-reviewed analyses instantly upon order, facilitating timely decision-making for clinicians [5]

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, taking place virtually from February 25-26, 2026. Management, including Ben Zeskind, Chief Executive Officer, and Brett Hall, Chief Scientific Officer, will discuss the company’s pipeline, platform, and busines ...

SINGAPORE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- RF Acquisition Corp III (the “Company”) today announced that it closed its initial public offering of up to 10,000,000 units at a price of $10.00 per unit on February 17, 2026. The units are listed on the Nasdaq Global Market (“Nasdaq”) and began trading under the ticker symbol “RFAMU” on February 13, 2026. Each unit consists of one ordinary share, par value $0.0001 per share, of the Company (“ordinary share”), and one right to receive one-tenth of one ordinary s ...

PERRYSBURG, Ohio, Feb. 18, 2026 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (“O-I Glass” or “O-I”) today announced the Company will participate in BofA Securities 2026 Global Agriculture and Materials Conference on Wednesday, February 25, 2026. O-I Glass Chief Financial Officer John Haudrich will present at 10:30 a.m. ET. A live webcast of the presentation will be available at https://bofa.veracast.com/webcasts/bofa/globalagriculture2026/RnXq1t.cfm or can be accessed on the Company’s Investor Relations website, www ...